Feedback / Questions
fipaxalparant (AMG 670) - Amgen
Fipaxalparant: Data from P2 trial (NCT05032066) for IPF in H2 2024
(Amgen)
-
Aug 7, 2024 -
Q2 2024 Results
P2 data
•
Idiopathic Pulmonary Fibrosis
https://investors.amgen.com/static-files/46d13760-0796-4940-93c5-2f6cde74bd4d
Aug 7, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious